Association study for single nucleotide polymorphisms in the CYP17A1 gene and polycystic ovary syndrome

International Journal of Molecular Medicine

Volumn 22, Issue 2, 2008, Pages 249-254

  Park, Jung Mi ^a   Lee, Eung Ji ^a   Ramakrishna, Suresh ^a   Cha, Dong Hyun ^a   Baek, Kwang Hyun ^a  

^a CHA University   (South Korea)

Author keywords

17 hydroxylase 17,20 lyase; Polycystic ovary syndrome; Single nucleotide polymorphism

Indexed keywords

ADENINE; CYTOCHROME P450 17; CYTOCHROME P450 17A1; CYTOSINE; GUANINE; THYMINE;

ALLELE; ANALYZER; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MISSENSE MUTATION; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; POPULATION RESEARCH; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; CHROMOSOMES, HUMAN, PAIR 10; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; KOREA; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; STEROID 17-ALPHA-HYDROXYLASE;

EID: 48749100273     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm_00000016     Document Type: Article

References (27)

1. Chang WY, Knochenhauer ES, Bartolucci AA and Azziz R: Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. Pertil Steril 83: 1717-1723, 2005.
2. Pasquali R and Gambineri A: Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age. Ann NY Acad Sci 1092: 158-174, 2006.
3. Byun EK, Kim HJ, Oh JY, Hong YS and Sung YA: The prevalence of polycystic ovary syndrome in college students from Seoul. J Kor Soc Endocrinol 20: 120-126, 2005.
4. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Hum Reprod 19: 41-47, 2004.
5. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81: 19-25, 2004.
6. Apridonidze T, Essah PA, Iuorno MJ and Nestler JE: Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 90: 1929-1935, 2005.
7. Franks S, Gharani N, Waterworth D, Batty S, White D, Williamson R and McCarthy M: Genetics of polycystic ovary syndrome. Mol Cell Endocrinol 145: 123-128, 1998.
8. Sheehan MT: Polycystic ovarian syndrome: diagnosis and management. Clin Med Res 2: 13-27, 2004.
9. Ehrmann DA, Liljenguist DR, Kasza K, Azziz R, Legro RS and Ghazzi MN: PCOS/Troglitazone Study Group: Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 91: 48-53, 2006.
10. Carey AH, Waterworth D, Patel K, White D, Little J, Novelli P, Franks S and Williamson R: Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet 3: 1873-1876, 1994.
11. Lee EJ, Yoo KJ, Kim SJ, Lee SH, Cha KY and Baek KH: Single nucleotide polymorphism in exon 17 of the insulin receptor gene is not associated with polycystic ovary syndrome in a Korean population. Fertil Steril 86: 380-384, 2006.
12. Lee EJ, Oh B, Lee JY, Kimm K, Lee SH and Baek KH: A single nucleotide polymorphism of INSR gene for polycystic ovary syndrome. Fertil Steril (In press).
13. Lee EJ, Oh B, Lee JY, Kimm K, Park JM and Baek KH: Association study between single nucleotide polymorphisms in the VEGF gene and polycystic ovary syndrome (POCS). Fertil Steril (In press).
14. Hansen L, Ekstrom CT, Tabanera Y, Palacios R, Anant M, Wassermann K and Reinhardt RR: The pro12Ala variant of the PPARG gene is a risk factor for PPARγ/α agonist induced edema in type 2 diabetic patients. J Clin Endocrinol Metab 91: 3446-3450, 2006.
15. Wood JR, Ho CK, Nelson-Degrave VL, McAllister JM and Strauss JF: The molecular signature of polycystic ovary syndrome (PCOS) theca cells defined by gene expression profiling. J Reprod Immunol 63: 51-60, 2004.
16. Doi SA, Al-Zaid M, Towers PA, Scott CJ and Al-Shoumer KA: Steroidogenic alterations and adrenal androgen excess in PCOS. Steroids 71: 751-759, 2006.
17. Genazzani AD, Lanzoni C, Ricchieri F, Baraldi E, Casarosa E and Jasonni VM: Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia. Gynecol Endocrinol 23: 146-152, 2007.
18. Lin JF, Li X and Zhu MW: Exploration of the classification of polycystic ovarian syndrome. Zhonghua Fu Chan Ke Za Zhi 41: 684-688, 2006.
19. Lim SK, Kim MS, Lee SH and Baek KH: Polymorphism of CYP17 and CYP11a for polycystic ovary syndrome in a Korean Population. Korean J Genetics 4: 343-348, 2002.
20. Akhtar MK, Kelly SL and Kaderbhai MA: Cytochrome b(5) modulation of 17αhydroxylase and 17-20 lyase (CYP17) activities in steroidogenesis. J Endocrinl 187: 267-274, 2005.
21. Techatraisak K, Conway GS and Rumsby G: Frequency of a polymorphism in the regulatory region of the 17 alpha-hydroxylase-17,20-lyase (CYP17) gene in hyperandrogenic states. Clin Endocrinol 46: 131-134, 1997.
22. Carmina E, Rosato F, Janni A, Rizzo M and Longo RA: Relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab 91: 2-6, 2006
23. Kim J, Park J, Kim S, Choi Y, Shin C, Moon S, Lee J and Chang Y: Clinical study on infertile women with oligomenorrhea. Kor J Obstet Gynecol 38: 824-826, 1995.
24. Gharani N, Waterworth DM, Batty S, White D, Gilling-Smith C, Conway GS, McCarthy M, Franks S and Williamson R: Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism. Hum Mol Genet 3: 397-402, 1997.
25. Dacou-Voutetakis C and Dracopoulou M: High Incidence of molecular defects of the CYP21 gene in patients with premature adrenarche. J Clin Endocrinol Metab 84: 1570-1574, 1999.
26. Olson SH, Bandera EV and Orlow I: Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE review. Am J Epidemiol 165: 235-245, 2007.
27. Mononen N, Seppala EH, Duqqal P, Autio V, Ikonen T, Ellonen P, Saharinen J, Saarela J, Vihinen M, Tammela TL, Kallioniemi O, Bailey-Wilson JE and Schleutker J: Profiling genetic variation along the androgen biosynthesis and metabolism pathways implicates several single nucleotide polymorphisms and their combinations as prostate cancer risk factors. Cancer Res 66: 743-747, 2006.